FI961029A0 - Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla - Google Patents

Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla

Info

Publication number
FI961029A0
FI961029A0 FI961029A FI961029A FI961029A0 FI 961029 A0 FI961029 A0 FI 961029A0 FI 961029 A FI961029 A FI 961029A FI 961029 A FI961029 A FI 961029A FI 961029 A0 FI961029 A0 FI 961029A0
Authority
FI
Finland
Prior art keywords
liver disease
management
procedure
corresponding indicators
vasodilating substances
Prior art date
Application number
FI961029A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961029A (fi
Inventor
Allan Joseph Mclean
Original Assignee
Mclean William Alexander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mclean William Alexander filed Critical Mclean William Alexander
Publication of FI961029A0 publication Critical patent/FI961029A0/fi
Publication of FI961029A publication Critical patent/FI961029A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
FI961029A 1993-09-08 1996-03-06 Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla FI961029A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM110493 1993-09-08
PCT/AU1994/000525 WO1995007080A1 (en) 1993-09-08 1994-09-05 A method of treating liver disease and like indications with vasodilating agents

Publications (2)

Publication Number Publication Date
FI961029A0 true FI961029A0 (fi) 1996-03-06
FI961029A FI961029A (fi) 1996-03-06

Family

ID=3777184

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961029A FI961029A (fi) 1993-09-08 1996-03-06 Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla

Country Status (14)

Country Link
EP (1) EP0717625B1 (de)
JP (1) JP3842815B2 (de)
KR (1) KR100350156B1 (de)
CN (1) CN1115151C (de)
AT (1) ATE218869T1 (de)
CA (1) CA2170289C (de)
DE (1) DE69430807T2 (de)
FI (1) FI961029A (de)
HK (1) HK1003422A1 (de)
IL (1) IL110888A (de)
NO (1) NO960866D0 (de)
NZ (1) NZ273242A (de)
SG (1) SG49645A1 (de)
WO (1) WO1995007080A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004008A1 (en) * 1990-09-07 1992-03-19 Universidad De Alicante Composition for treating ocular pain
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation

Also Published As

Publication number Publication date
NZ273242A (en) 2001-04-27
ATE218869T1 (de) 2002-06-15
DE69430807T2 (de) 2002-12-19
NO960866L (no) 1996-03-04
JP3842815B2 (ja) 2006-11-08
DE69430807D1 (de) 2002-07-18
CN1115151C (zh) 2003-07-23
EP0717625A4 (de) 1997-12-29
NO960866D0 (no) 1996-03-04
CA2170289C (en) 2001-05-08
KR100350156B1 (ko) 2003-02-14
EP0717625B1 (de) 2002-06-12
SG49645A1 (en) 1999-10-19
CA2170289A1 (en) 1995-03-16
WO1995007080A1 (en) 1995-03-16
CN1130874A (zh) 1996-09-11
HK1003422A1 (en) 1998-10-30
FI961029A (fi) 1996-03-06
JPH09502188A (ja) 1997-03-04
IL110888A0 (en) 1994-11-28
EP0717625A1 (de) 1996-06-26
IL110888A (en) 1999-07-14

Similar Documents

Publication Publication Date Title
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
PT850068E (pt) Extracto lipidico com actividade anti-inflamatoria
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
ATE340581T1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
DE59808999D1 (de) Vorrichtung zur verabreichung einer infusion und/oder perfusion an einen patienten
DE69531104D1 (de) Transdermales system zur verabreichung durch entepithelisierte haut
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
EE9900428A (et) Köhavastased ravimkoostised
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
NO992674D0 (no) Konturen til et transdermalt terapeutisk system
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
FI961029A (fi) Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
AR003979A1 (es) Administracion transdermica de vorozol.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
TR200202103T2 (tr) ''5-[{6-(2-Flüorobenzil)oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri''
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ITRM920084U1 (it) Siringa per iniezioni medicali monouso con dispositivo per la scomparsa dell'ago dopo l'uso.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACY AND THERAPEUTIC ADVISORY